These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment. Kawai K, Hata K, Takaoka H, Kawai H, Yokoyama M. Am Heart J; 2001 Jun; 141(6):925-32. PubMed ID: 11376305 [Abstract] [Full Text] [Related]
7. Myocardial contractile reserve under low doses of dobutamine and improvement of left ventricular ejection fraction with treatment by carvedilol. Jourdain P, Funck F, Fulla Y, Hagege A, Bellorini M, Guillard N, Loiret J, Thebault B, Desnos M. Eur J Heart Fail; 2002 Jun; 4(3):269-76. PubMed ID: 12034151 [Abstract] [Full Text] [Related]
13. Improvement of cardiac neuronal function after carvedilol treatment in dilated cardiomyopathy: a 123I-MIBG scintigraphic study. Agostini D, Belin A, Amar MH, Darlas Y, Hamon M, Grollier G, Potier JC, Bouvard G. J Nucl Med; 2000 May; 41(5):845-51. PubMed ID: 10809201 [Abstract] [Full Text] [Related]
17. Decreased myocardial beta-adrenergic receptor density in relation to increased sympathetic tone in patients with nonischemic cardiomyopathy. Tsukamoto T, Morita K, Naya M, Inubushi M, Katoh C, Nishijima K, Kuge Y, Okamoto H, Tsutsui H, Tamaki N. J Nucl Med; 2007 Nov; 48(11):1777-82. PubMed ID: 17942801 [Abstract] [Full Text] [Related]
18. Improvement in left ventricular function in response to carvedilol is accompanied by attenuation of neurohumoral activation in patients with dilated cardiomyopathy. Fujimura M, Yasumura Y, Ishida Y, Nakatani S, Komamura K, Yamagishi M, Miyatake K. J Card Fail; 2000 Mar; 6(1):3-10. PubMed ID: 10746813 [Abstract] [Full Text] [Related]